EXPLORE CONNECTIONS
Discovery of a new drug using lipid-based formulation targeting G12D mutated KRAS4B through non-covalent bonds
Follow the relationships that help you find your next source.
Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.